Greetings. Welcome to the SWK Holdings Fourth Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.

SWK Holdings Corp (SWKH), with a market capitalization of $208 million, reported robust financial results for the fourth quarter of 2024, showcasing a significant rise in key performance metrics.

In March 2025, through two transactions SWK monetized its performing royalty portfolio for approximately $51.3 million and anticipates declaring a dividend on the closing of the larger transaction.

On March 17, 2025, ANI Pharmaceuticals, Inc. exercised its buyout option related to the Iluvien royalty, which resulted in a payment of approximately $17.3 million to SWK.

Zeit Aktuelle Nachrichten 20.03. SWK Holdings GAAP EPS of $0.48 misses by $0.25, revenue of $12.36M 20.03. SWK Holdings Corp - 8-K, Current Report 20.03. SWK Holdings Corp - 10-K, Annual Report 20 ...

DALLAS, TX / ACCESS Newswire / March 19, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized ...

The company generated approximately $15.4 billion in 2024 revenue. SWK operates within a divisional structure, with approximately 85% of revenue coming from the Tools and Storage segment ...